Terms & Conditions
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
WVE-N531 Shows Sustained Dystrophin Production in Phase 2 Trial of Duchenne Muscular Dystrophy
2
FDA Action Update, February 2026: Complete Response Letter, Expanded Indication, and Acceptance
3
Real-World Study Suggests Motor Gains in SMA After Switching to Onasemnogene Abeparvovec From Nusinersen or Risdiplam Treatment
4
Phase 3 STELLAR Studies to Test the Efficacy of Salanersen in Presymptomatic Newborns With SMA
5